Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

The burden and measurement of cardiovascular disease in SSc

Abstract

The prognosis for patients with systemic sclerosis (SSc) has improved in the past three decades, with fewer patients succumbing to renal-crisis-related death. While pulmonary fibrosis and hypertension are currently the most frequent causes of death, there is evidence that cardiovascular disease will have an important role in the long-term prognosis of SSc in the future. Ischemia–reperfusion injury and endothelial dysfunction are cardinal features of SSc, and may predispose a patient to microvascular disease and atherosclerosis. In order to alleviate the cardiovascular burden in patients with SSc, it is important to detect endothelial dysfunction, microvascular flow disturbance and atherosclerosis. Noninvasive techniques that evaluate flow-mediated dilatation and arterial pulse waves (endothelial function measurements), microvascular blood flow (measurement of the microcirculation), carotid intima–media thickness and left ventricular hypertrophy (detection of atherosclerosis) are recommended. In addition, these measurements will facilitate trials of therapeutic strategies that, in addition to controlling conventional risk factors, prevent and treat cardiovascular disease in patients with SSc.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Proposed model of development of cardiovascular disease in systemic sclerosis.
Figure 2: Ischemia–reperfusion injury causing endothelial dysfunction in systemic sclerosis.
Figure 3: Endothelial dysfunction and oxidative stress in the pathogenesis of atherosclerosis.

Similar content being viewed by others

References

  1. Szekanecz, Z. & Koch, A. E. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res. Ther. 10, 224 (2008).

    Article  Google Scholar 

  2. Karassa, F. B. & Ioannidis, J. P. Mortality in systemic sclerosis. Clin. Exp. Rheumatol. 26 (5 Suppl. 51), S85–S93 (2008).

    CAS  PubMed  Google Scholar 

  3. Steen, V. D. & Medsger, T. A. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum. Dis. 66, 940–944 (2007).

    Article  Google Scholar 

  4. Ferri, C. et al. Systemic sclerosis: demographic, clinical and serological features and survival in 1,012 Italian patients. Medicine (Baltimore) 81, 139–153 (2002).

    Article  Google Scholar 

  5. Hettema, M. E., Bootsma, H. & Kallenberg, C. G. M. Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 47, 578–583 (2008).

    Article  CAS  Google Scholar 

  6. Fukuda, D., Enomoto, S., Nagai, R. & Sata, M. Inhibition of renin–angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. Biomed. Pharmacother. 63, 754–761 (2009).

    Article  CAS  Google Scholar 

  7. Youssef, P., Brama, T., Englert, H. & Bertouch, J. Limited scleroderma is associated with increased prevalence of macrovascular disease. J. Rheumatol. 22, 469–472 (1995).

    CAS  PubMed  Google Scholar 

  8. Ho, M., Veale, D., Eastmond, C., Nuki, G. & Belch, J. Macrovascular disease and systemic sclerosis. Ann. Rheum. Dis. 59, 39–43 (2000).

    Article  CAS  Google Scholar 

  9. Sulli, A. et al. Blunted coronary flow reserve in systemic sclerosis. Rheumatology (Oxford) 43, 505–509 (2004).

    Article  CAS  Google Scholar 

  10. Khurma, V. et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum. 59, 591–597 (2008).

    Article  CAS  Google Scholar 

  11. Jacobsen, S., Halberg, P. & Ullman, S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br. J. Rheumatol. 37, 750–755 (1993).

    Article  Google Scholar 

  12. Ad-Dhaher, F. F., Pope, J. E. & Oiumet, J. M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 39, 269–277 (2010).

    Article  Google Scholar 

  13. Akram, M. R. et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 45, 1395–1398 (2006).

    Article  CAS  Google Scholar 

  14. Follansbee, W. P. et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N. Engl. J. Med. 310, 142–148 (1984).

    Article  CAS  Google Scholar 

  15. Follansbee, W. P. et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J. Rheumatol. 17, 656–662 (1990).

    CAS  PubMed  Google Scholar 

  16. Abraham, D. J., Krieq, T., Distler, J. & Distler, O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 48 (Suppl. 3), 3–7 (2009).

    Google Scholar 

  17. Le Brocq, M., Leslie, S. J., Milliken, P. & Megson, I. L. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid. Redox Signal. 10, 1631–1674 (2008).

    Article  CAS  Google Scholar 

  18. Derrett-Smith, E. C., Denton, C. P. & Sonnylal, S. Animal models of scleroderma: lessons from transgenic and knockout mice. Curr. Opin. Rheumatol. 21, 630–635 (2009).

    Article  Google Scholar 

  19. Doria, A., Sherer, Y., Meroni, P. L. & Shoenfeld, Y. Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum. Dis. Clin. N. Am. 31, 355–362 (2005).

    Article  Google Scholar 

  20. Boin, F. et al. Independent association of anti-β2-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum. 60, 2480–2489 (2009).

    Article  Google Scholar 

  21. Celermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J. & Deanfield, J. E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24, 1468–1474 (1994).

    Article  CAS  Google Scholar 

  22. Bartoli, F. et al. Flow-mediated vasodilation and carotid intima–media thickness in systemic sclerosis. Ann. NY Acad. Sci. 1108, 283–290 (2007).

    Article  Google Scholar 

  23. Szücs, G. et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications. Rheumatology (Oxford) 46, 759–762 (2007).

    Article  Google Scholar 

  24. Timár, O. et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J. Rheumatol. 35, 1329–1333 (2008).

    PubMed  Google Scholar 

  25. Turner, J., Belch, J. J. & Khan, F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc. Med. 18, 109–116 (2008).

    Article  CAS  Google Scholar 

  26. Murray, A. K. et al. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum. 61, 1103–1111 (2009).

    Article  Google Scholar 

  27. de Groot, E. et al. Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 5, 280–288 (2008).

    Article  Google Scholar 

  28. de Groot, P. et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann. Rheum. Dis. 67, 31–36 (2008).

    Article  Google Scholar 

  29. Greenland, P. et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 49, 378–402 (2007).

    Article  Google Scholar 

  30. Mok, M. Y. et al. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand. J. Rheumatol. 38, 381–385 (2009).

    Article  CAS  Google Scholar 

  31. Kobaysahi, H. et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J. Rheumatol. 36, 106–112 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chak Sing Lau.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mok, M., Lau, C. The burden and measurement of cardiovascular disease in SSc. Nat Rev Rheumatol 6, 430–434 (2010). https://doi.org/10.1038/nrrheum.2010.65

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2010.65

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing